Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-07-008548
Filing Date
2007-04-27
Accepted
2007-04-27 16:50:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 424(B)(3) SUPPLEMENT 2 prospectussupp2.htm 424B3 43942
2 LOGO biosantelogo6.jpg GRAPHIC 13169
  Complete submission text file 0001140361-07-008548.txt   63727
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-116110 | Film No.: 07796486
SIC: 2836 Biological Products, (No Diagnostic Substances)